Publications

  1. Van Treeck BJ, Lotfalla M, Czeczok TW, Mounajjed T, Moreira RK, Allende DS, Reid MD, Naini BV, Westerhoff M, Adsay NV, Kerr SE, Rizvi SH, Smoot RL, Liu Y, Davila J, Graham RP. Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the Liver. Am J Clin Pathol. 2020 Nov 4; 154 (6):837-847
    View PubMed
  2. Starlinger P, Pereyra D, Hackl H, Ortmayr G, Braunwarth E, Santol J, Najarnia S, Driedger MR, Gregory L, Alva-Ruiz R, Glasgow A, Assinger A, Nagorney DM, Habermann EB, Staetttner S, Cleary SP, Smoot RL, Gruenberger T. Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment during Hepatic Surgery. Hepatology. 2020 Oct 20 [Epub ahead of print]
    View PubMed
  3. Driedger MR, Groeschl R, Yohanathan L, Starlinger P, Grotz TE, Smoot RL, Nagorney DM, Cleary SP, Kendrick ML, Truty MJ. Finding the Balance: General Surgery Resident Versus Fellow Training and Exposure in Hepatobiliary and Pancreatic Surgery. J Surg Educ. 2020 Oct 16 [Epub ahead of print]
    View PubMed
  4. Loeuillard E, Yang J, Buckarma E, Wang J, Liu Y, Conboy C, Pavelko KD, Li Y, O'Brien D, Wang C, Graham RP, Smoot RL, Dong H, Rizvi S, Ilyas S. Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma. J Clin Invest. 2020 Oct 1; 130 (10):5380-5396
    View PubMed
  5. Buckarma EH, Werneburg NW, Conboy CB, Kabashima A, O'Brien DR, Wang C, Rizvi S, Smoot RL. The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma. Mol Cancer Res. 2020 Oct; 18 (10):1574-1588 Epub 2020 July 09
    View PubMed
  6. Driedger MR, Puig CA, Thiels CA, Bergquist JR, Ubl DS, Habermann EB, Grotz TE, Smoot RL, Nagorney DM, Cleary SP, Kendrick ML, Truty MJ. Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients. BMC Surg. 2020 Jul 27; 20 (1):169 Epub 2020 July 27
    View PubMed
  7. Buckarma E, Thiels CA, Habermann EB, Glasgow A, Grotz TE, Cleary SP, Smoot RL, Kendrick ML, Nagorney DM, Truty MJ. Preoperative opioid use is associated with increased length of stay after pancreaticoduodenectomy. HPB (Oxford). 2020 Jul; 22 (7):1074-1081 Epub 2019 Dec 12
    View PubMed
  8. Lehrke HD, Van Treeck BJ, Allende D, Denham LJ, Gonzalez RS, Moreira RK, Mounajjed T, Naini BV, Smoot RL, Zreik RT, Jenkins S, Graham RP. Does Argininosuccinate Synthase 1 (ASS1) Immunohistochemistry Predict an Increased Risk of Hemorrhage for Hepatocellular Adenomas? Appl Immunohistochem Mol Morphol. 2020 Jul; 28 (6):464-470
    View PubMed
  9. Truty MJ, Colglazier JJ, Mendes BC, Nagorney DM, Bower TC, Smoot RL, DeMartino RR, Cleary SP, Oderich GS, Kendrick ML. En Bloc Celiac Axis Resection for Pancreatic Cancer: Classification of Anatomical Variants Based on Tumor Extent. J Am Coll Surg. 2020 Jul; 231 (1):8-29 Epub 2020 May 15
    View PubMed
  10. Bernts LHP, Neijenhuis MK, Edwards ME, Sloan JA, Fischer J, Smoot RL, Nagorney DM, Drenth JPH, Hogan MC. Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease. Surgery. 2020 Jul; 168 (1):25-32 Epub 2020 May 08
    View PubMed
  11. Werneburg N, Gores GJ, Smoot RL. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies. Gene Expr. 2020 Jun 12; 20 (1):67-74 Epub 2019 June 28
    View PubMed
  12. Maeda S, Moore AM, Yohanathan L, Hata T, Truty MJ, Smoot RL, Cleary SP, Nagorney DM, Grotz TE, Park EJ, Girgis MD, Reber HA, Motoi F, Masuda T, Unno M, Kendrick ML, Donahue TR. Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy. Surgery. 2020 May; 167 (5):803-811 Epub 2020 Jan 25
    View PubMed
  13. Leiting JL, Murphy SJ, Bergquist JR, Hernandez MC, Ivanics T, Abdelrahman AM, Yang L, Lynch I, Smadbeck JB, Cleary SP, Nagorney DM, Torbenson MS, Graham RP, Roberts LR, Gores GJ, Smoot RL, Truty MJ. Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine. JHEP Rep. 2020 Apr; 2 (2):100068 Epub 2020 Jan 16
    View PubMed
  14. Yadav S, Tella SH, Kommalapati A, Mara K, Prasai K, Mady MH, Hassan M, Smoot RL, Cleary SP, Truty MJ, Roberts LR, Mahipal A. A Novel Clinically Based Staging System for Gallbladder Cancer. J Natl Compr Canc Netw. 2020 Feb; 18 (2):151-159
    View PubMed
  15. Sugimoto M, Takahashi N, Farnell MB, Smyrk TC, Truty MJ, Nagorney DM, Smoot RL, Chari ST, Carter RE, Kendrick ML. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis. J Surg Oncol. 2019 Nov; 120 (6):976-984 Epub 2019 Aug 26
    View PubMed
  16. Rustagi T, Gleeson FC, Chari ST, Lehrke HD, Takahashi N, Malikowski TM, Abu Dayyeh BK, Chandrasekhara V, Iyer PG, Kendrick ML, Pearson RK, Petersen BT, Rajan E, Smoot RL, Storm AC, Topazian MD, Truty MJ, Vege SS, Wang KK, Levy MJ. Safety, Diagnostic Accuracy, and Effects of Endoscopic Ultrasound Fine-Needle Aspiration on Detection of Extravascular Migratory Metastases. Clin Gastroenterol Hepatol. 2019 Nov; 17 (12):2533-2540.e1 Epub 2019 Apr 03
    View PubMed
  17. Bergquist JR, Leiting JL, Habermann EB, Cleary SP, Kendrick ML, Smoot RL, Nagorney DM, Truty MJ, Grotz TE. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery. 2019 Oct; 166 (4):547-555 Epub 2019 July 20
    View PubMed
  18. Yadav S, Xie H, Bin-Riaz I, Sharma P, Bin-Riaz I, Durani U, Goyal G, Borah B, Borad MJ, Smoot RL, Roberts LR, Go RS, McWilliams RR, Mahipal A. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis. Eur J Surg Oncol. 2019 Aug; 45 (8):1432-1438 Epub 2019 Mar 21
    View PubMed
  19. Chakrabarti S, Tella SH, Kommalapati A, Huffman BM, Yadav S, Riaz IB, Goyal G, Mody K, Borad M, Cleary S, Smoot RL, Mahipal A. Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma. J Gastrointest Oncol. 2019 Jun; 10 (3):554-561
    View PubMed
  20. Sugihara T, Isomoto H, Gores G, Smoot R. YAP and the Hippo pathway in cholangiocarcinoma. J Gastroenterol. 2019 Jun; 54 (6):485-491 Epub 2019 Feb 27
    View PubMed
  21. Hernandez MC, Bergquist JR, Leiting JL, Ivanics T, Yang L, Smoot RL, Nagorney DM, Truty MJ. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens. J Gastrointest Surg. 2019 Apr; 23 (4):818-824 Epub 2019 Feb 12
    View PubMed
  22. Hori Y, Vege SS, Chari ST, Gleeson FC, Levy MJ, Pearson RK, Petersen BT, Kendrick ML, Takahashi N, Truty MJ, Smoot RL, Topazian MD. Classic chronic pancreatitis is associated with prior acute pancreatitis in only 50% of patients in a large single-institution study. Pancreatology. 2019 Mar; 19 (2):224-229 Epub 2019 Feb 12
    View PubMed
  23. Hernandez MC, Panchamia J, Finnesgard EJ, Leiting JL, Franssen B, Saleem H, Kendrick ML, Nagorney DM, Truty MJ, Smoot RL. Transversus abdominis plane blocks with liposomal bupivacaine after open major hepatectomy is associated with reduced early patient-reported pain scores and opioid administration. Surgery. 2018 Dec; 164 (6):1251-1258 Epub 2018 Sept 07
    View PubMed
  24. Kamboj AK, Stroh GR, Smoot RL, Prichard DO. A Rare Case of Recurrent Small Bowel Obstructions. Gastroenterology. 2018 Nov; 155 (5):e5-e7 Epub 2018 June 05
    View PubMed
  25. Sugihara T, Werneburg NW, Hernandez MC, Yang L, Kabashima A, Hirsova P, Yohanathan L, Sosa C, Truty MJ, Vasmatzis G, Gores GJ, Smoot RL. YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity. Mol Cancer Res. 2018 Oct; 16 (10):1556-1567 Epub 2018 June 14
    View PubMed
  26. Tee MC, Krajewski AC, Groeschl RT, Farnell MB, Nagorney DM, Kendrick ML, Cleary SP, Smoot RL, Croome KP, Truty MJ. Indications and Perioperative Outcomes for Pancreatectomy with Arterial Resection. J Am Coll Surg. 2018 Aug; 227 (2):255-269 Epub 2018 May 09
    View PubMed
  27. Johnson B, Jin Z, Haddock MG, Hallemeier CL, Martenson JA, Smoot RL, Larson DW, Dozois EJ, Nagorney DM, Grothey A. A Curative-Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single-Institutional Experience. Oncologist. 2018 Jun; 23 (6):679-685 Epub 2018 Feb 14
    View PubMed
  28. Sugimoto M, Farnell MB, Nagorney DM, Kendrick ML, Truty MJ, Smoot RL, Chari ST, Moynagh MR, Petersen GM, Carter RE, Takahashi N. Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg. 2018 May; 22 (5):831-839 Epub 2018 Feb 01
    View PubMed
  29. Costa AF, Tremblay St-Germain A, Abdolell M, Smoot RL, Cleary S, Jhaveri KS. How Do Different Indices of Hepatic Enhancement With Gadoxetic Acid Compare in Predicting Liver Failure and Other Major Complications After Hepatectomy? J Comput Assist Tomogr. 2018 May/Jun; 42 (3):380-386
    View PubMed
  30. Bergquist JR, Shah HN, Habermann EB, Hernandez MC, Ivanics T, Kendrick ML, Smoot RL, Nagorney DM, Borad MJ, McWilliams RR, Truty MJ. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study). Int J Surg. 2018 Apr; 52:171-179 Epub 2018 Feb 26
    View PubMed
  31. Shubert CR, Kendrick ML, Habermann EB, Glasgow AE, Borah BJ, Moriarty JP, Cleary SP, Smoot RL, Farnell MB, Nagorney DM, Truty MJ, Que FG. Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million. Surgery. 2018 Mar; 163 (3):495-502 Epub 2017 Dec 21
    View PubMed
  32. Rizvi S, Fischbach SR, Bronk SF, Hirsova P, Krishnan A, Dhanasekaran R, Smadbeck JB, Smoot RL, Vasmatzis G, Gores GJ. YAP-associated chromosomal instability and cholangiocarcinoma in mice. Oncotarget. 2018 Jan 19; 9 (5):5892-5905 Epub 2017 Dec 22
    View PubMed
  33. Smoot RL, Werneburg NW, Sugihara T, Hernandez MC, Yang L, Mehner C, Graham RP, Bronk SF, Truty MJ, Gores GJ. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation. J Cell Biochem. 2018 Jan; 119 (1):824-836 Epub 2017 Aug 03
    View PubMed
  34. Johnson B, Jin Z, Truty MJ, Smoot RL, Nagorney DM, Kendrick ML, Kipp BR, Grothey A. Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience. Oncologist. 2018 Jan; 23 (1):128-134 Epub 2017 Sept 13
    View PubMed
  35. Costa AF, Tremblay St-Germain A, Abdolell M, Smoot RL, Cleary S, Jhaveri KS. Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection? Clin Radiol. 2017 Jul; 72 (7):598-605 Epub 2017 Mar 06
    View PubMed
  36. Bergquist JR, Ivanics T, Shubert CR, Habermann EB, Smoot RL, Kendrick ML, Nagorney DM, Farnell MB, Truty MJ. Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer. Ann Surg Oncol. 2017 Jun; 24 (6):1731-1738 Epub 2017 Jan 09
    View PubMed
  37. Thompson SM, Zendejas-Mummert B, Hartgers ML, Venkatesh SK, Smyrk TC, Mahipal A, Smoot RL. Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor. J Gastrointest Oncol. 2016 Dec; 7 (6):E107-E112
    View PubMed
  38. Jaberi A, Toor SS, Rajan DK, Mironov O, Kachura JR, Cleary SP, Smoot R, Tremblay St-Germain A, Tan K. Comparison of Clinical Outcomes following Glue versus Polyvinyl Alcohol Portal Vein Embolization for Hypertrophy of the Future Liver Remnant prior to Right Hepatectomy. J Vasc Interv Radiol. 2016 Dec; 27: (12)1897-1905.e1.
    View PubMed
  39. Shubert CR, Ferrone CR, Fernandez-Del Castillo C, Kendrick ML, Farnell MB, Smoot RL, Truty MJ, Que FG. A multicenter randomized controlled trial comparing pancreatic leaks after TissueLink versus SEAMGUARD after distal pancreatectomy (PLATS) NCT01051856. J Surg Res. 2016 Nov; 206 (1):32-40 Epub 2016 June 17
    View PubMed
  40. Bergquist JR, Groeschl RT, Ivanics T, Shubert CR, Habermann EB, Kendrick ML, Farnell MB, Nagorney DM, Truty MJ, Smoot RL. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics. HPB (Oxford). 2016 Nov; 18 (11):886-892 Epub 2016 Aug 18
    View PubMed
  41. Ivanics T, Bergquist JR, Shubert CR, Smoot RL, Habermann EB, Truty MJ. Small Cell Carcinoma of the Pancreas: A Surgical Disease. Pancreas. 2016 Nov; 45 (10):1461-1466
    View PubMed
  42. Shubert CR, Bergquist JR, Groeschl RT, Habermann EB, Wilson PM, Truty MJ, Smoot RL, Kendrick ML, Nagorney DM, Farnell MB. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database. Surgery. 2016 Oct; 160 (4):1080-1096 Epub 2016 Aug 10
    View PubMed
  43. Bergquist JR, Ivanics T, Storlie CB, Groeschl RT, Tee MC, Habermann EB, Smoot RL, Kendrick ML, Farnell MB, Roberts LR, Gores GJ, Nagorney DM, Truty MJ. Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. J Surg Oncol. 2016 Sep; 114 (4):475-82 Epub 2016 July 20
    View PubMed
  44. Zeb MH, Pandian TK, El Khatib MM, Naik ND, Chandra A, Morris DS, Smoot RL, Farley DR. Risk factors for postoperative hematoma after inguinal hernia repair: an update. J Surg Res. 2016 Sep; 205 (1):33-7 Epub 2016 June 08
    View PubMed
  45. Bergquist JR, Puig CA, Shubert CR, Groeschl RT, Habermann EB, Kendrick ML, Nagorney DM, Smoot RL, Farnell MB, Truty MJ. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study. J Am Coll Surg. 2016 Jul; 223 (1):52-65 Epub 2016 Feb 23
    View PubMed
  46. Thiels CA, Bergquist JR, Laan DV, Croome KP, Smoot RL, Nagorney DM, Thompson GB, Kendrick ML, Farnell MB, Truty MJ. Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified? J Gastrointest Surg. 2016 May; 20 (5):891-8 Epub 2016 Feb 29
    View PubMed
  47. Tee MC, Ubl DS, Habermann EB, Nagorney DM, Kendrick ML, Sarr MG, Truty MJ, Que FG, Reid-Lombardo K, Smoot RL, Farnell MB. Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy. J Gastrointest Surg. 2016 Jan; 20 (1):189-98; discussion 198 Epub 2015 Nov 09
    View PubMed
  48. Tee MC, Croome KP, Shubert CR, Farnell MB, Truty MJ, Que FG, Reid-Lombardo KM, Smoot RL, Nagorney DM, Kendrick ML. Laparoscopic pancreatoduodenectomy does not completely mitigate increased perioperative risks in elderly patients. HPB (Oxford). 2015 Oct; 17 (10):909-18 Epub 2015 Aug 20
    View PubMed
  49. Shubert CR, Wagie AE, Farnell MB, Nagorney DM, Que FG, Reid Lombardo KM, Truty MJ, Smoot RL, Kendrick ML. Clinical Risk Score to Predict Pancreatic Fistula after Pancreatoduodenectomy: Independent External Validation for Open and Laparoscopic Approaches. J Am Coll Surg. 2015 Sep; 221 (3):689-98 Epub 2015 May 21
    View PubMed
  50. Lee JJ, Conneely JB, Smoot RL, Gallinger S, Greig PD, Moulton CA, Wei A, McGilvray I, Cleary SP. Laparoscopic versus open liver resection for hepatocellular carcinoma at a North-American Centre: a 2-to-1 matched pair analysis. HPB (Oxford). 2015 Apr; 17: (4)304-10.
    View PubMed
  51. Razumilava N, Gradilone SA, Smoot RL, Mertens JC, Bronk SF, Sirica AE, Gores GJ. Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma. J Hepatol. 2014 Mar; 60 (3):599-605 Epub 2013 Nov 14
    View PubMed
  52. Conneely JB, Smoot RL, Greig PD, McGilvray ID. Mesocaval shunting. J Am Coll Surg. 2014; 218(2):306-7.
  53. Mertens JC, Fingas CD, Christensen JD, Smoot RL, Bronk SF, Werneburg NW, Gustafson MP, Dietz AB, Roberts LR, Sirica AE, Gores GJ. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Res. 2013 Jan 15; 73 (2):897-907 Epub 2012 Dec 05
    View PubMed
  54. Smoot RL, Donohue JH. Modified Appleby procedure for resection of tumors of the pancreatic body and tail with celiac axis involvement. J Gastrointest Surg. 2012 Nov; 16 (11):2167-9 Epub 2012 June 14
    View PubMed
  55. Zaydfudim V, Smoot RL, Clark CJ, Kendrick ML, Que FG, Farnell MB, Nagorney DM. Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinoma. J Gastrointest Surg. 2012 Aug; 16 (8):1516-23 Epub 2012 May 30
    View PubMed
  56. Razumilava N, Bronk SF, Smoot RL, Fingas CD, Werneburg NW, Roberts LR, Mott JL. miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology. 2012 Feb; 55 (2):465-75 Epub 2011 Dec 19
    View PubMed
  57. Smoot RL, Nagorney DM, Chandan VS, Que FG, Schleck CD, Harmsen WS, Kendrick ML. Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg. 2011 May; 98(5):697-703. Epub 2011 Jan 31.
    View PubMed
  58. Schnelldorfer T, Ware AL, Smoot R, Schleck CD, Harmsen WS, Nagorney DM. Management of giant hemangioma of the liver: resection versus observation. J Am Coll Surg. 2010 Dec; 211(6):724-30. Epub 2010 Oct 25.
    View PubMed
  59. Fingas CD, Blechacz BR, Smoot RL, Guicciardi ME, Mott J, Bronk SF, Werneburg NW, Sirica AE, Gores GJ. A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells. Hepatology. 2010 Aug; 52 (2):550-61
    View PubMed
  60. Smoot RL, Blechacz BR, Werneburg NW, Bronk SF, Sinicrope FA, Sirica AE, Gores GJ. A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells. Cancer Res. 2010 Mar 1; 70 (5):1960-9 Epub 2010 Feb 16
    View PubMed
  61. Blechacz BR, Smoot RL, Bronk SF, Werneburg NW, Sirica AE, Gores GJ. Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2. Hepatology. 2009 Dec; 50 (6):1861-70
    View PubMed
  62. Camp CL, Smoot RL, Kolettis TN, Groenewald CB, Greenlee SM, Farley DR. Patient records at Mayo Clinic: lessons learned from the first 100 patients in Dr Henry S. Plummer's dossier model. Mayo Clin Proc 2008 Dec; 83 (12):1396-9
    View PubMed
  63. Smoot RL, Zhang L, Sebo TJ, Que FG. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care. J Am Coll Surg. 2008 Sep; 207(3):368-70. Epub 2008 May 15.
    View PubMed
  64. Smoot RL, Oderich GS, Taner CB, Greenlee SM, Larson DR, Cragun EB, Farley DR. Postoperative hematoma following inguinal herniorrhaphy: patient characteristics leading to increased risk. Hernia. 2008 Jun; 12 (3):261-5 Epub 2007 Dec 04
    View PubMed
  65. Smoot RL, Farley DR. Why wouldn't this elderly man get up and move? Contemp Surg. 2008 Apr; 64(6):179-81.
  66. Truty MJ, Smoot RL. Animal models in pancreatic surgery: a plea for pork. Pancreatology. 2008; 8(6):546-50. Epub 2008 Sep 30.
    View PubMed
  67. Smoot RL, Christein JD, Farnell MB. An innovative option for venous reconstruction after pancreaticoduodenectomy: the left renal vein. J Gastrointest Surg. 2007 Apr; 11 (4):425-31
    View PubMed
  68. Mahadeo DC, Janka-Junttila M, Smoot RL, Roselova P, Parent CA. A chemoattractant-mediated Gi-coupled pathoway activates adenylyl cyclase in human neutrophils. Mol Biol Cell. Feb 2007; 18(2):512-22. Epub 2006 Nov
  69. Smoot RL, Christein JD, Farnell MB. Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg. 2006 Dec; 10 (10):1371-5
    View PubMed
  70. Smoot RL, Farley DR. Minnesota general surgeons. Where do they come from? Minn Med. 2006 Dec; 89 (12):46-8
    View PubMed
  71. Smoot RL, Koch CA, Degnim AC, Sterioff S, Donohue JH, Grant CS, Barnes SA, Gullerud RE, Hobday TJ, Farley DR. A single-center experience with inflammatory breast cancer, 1985-2003. Arch Surg. 2006 Jun; 141(6):567-72; discussion 572-3.
    View PubMed
  72. Wacker MJ, Best SR, Kosloski LM, Stachura CJ, Smoot RL, Porter CB, Orr JA. Thromboxane A2-induced arrhythmias in the anesthetized rabbit. Am J Physiol Heart Circ Physiol. 2006 Apr; 290: (4)H1353-61.
    View PubMed
  73. Christein JD, Smoot RL, Farnell MB. Central pancreatectomy: a technique for the resection of pancreatic neck lesions. Arch Surg. 2006 Mar; 141: (3)293-9.
    View PubMed
  74. Smoot RL, Taner CB, Farley DR. An axillary mass with no primary source. Contemp Surg. 2006; 62(4):171-6.
  75. Smoot RL, Peoples JT, Hanson GJ, Zietlow SP, Donnelly SF. Adults: More Common Than You Think Resident and Staff Physician. 2005; 51(12):7-12.
  76. Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol. 2004 Aug; 99(8):1579-84.
    View PubMed
  77. Smoot RL, Farres H, Taner CB. When a Small-Bowel Diverticulum Perforates Contemp Surg. Contemp Surg. July; 60(7):319-322. Epub 2004
  78. Smoot RL, Gostout CJ, Rajan E, Pardi DS, Schleck CD, Harmsen WS, Zinsmeister AR, Nolte T, Melton LJ. Is early colonoscopy after admission for acute diverticular bleeding needed? Am J Gastroenterol. 2003 Sep; 98(9):1996-9.
    View PubMed
  79. Feitoza AB, Gostout CJ, Rajan E, Smoot RL, Burgart LJ, Schleck C, Zinsmeister AR. Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plications. Gastrointest Endosc. 2003 Jun; 57 (7):868-76
    View PubMed
  80. Wacker MJ, Tehrani RN, Smoot RL, Orr JA. Thromboxane A(2) mimetic evokes a bradycardia mediated by stimulation of cardiac vagal afferent nerves. Am J Physiol Heart Circ Physiol. 2002 Feb; 282(2):H482-90.
    View PubMed